A single institutional experience with 43 pregnancies in essential thrombocythemia

Curtis A. Wright, Ayalew Tefferi

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

Objectives: We describe the periconception circumstances and outcome of 43 consecutive pregnancies in an unselected group of young women with essential thrombocythemia (ET). Patients and methods: We retrospectively studied 74 consecutive cases of young women with ET seen at our institution, among whom 43 pregnancies occurred in 20 patients. Results: Of the 43 pregnancies, 22 (51%) were successful (21 term and 1 preterm live births) and 21 (49%) ended in miscarriages (1 ectopic pregnancy, 2 elective abortions, 16 first-trimester spontaneous abortions, 1 stillbirth at 22 wk, and 1 abruptio placentae at 33 wk). Management of ET at the time of conception included either no specific therapy (16 cases) or the use of aspirin alone (24 cases), a cytoreductive agent (2 cases), or heparin (1 case). There were no significant differences with respect to platelet count or the effect of treatment with aspirin, either at the time of conception or during the first trimester, among cases of successful pregnancies (22), all miscarriages (21), or first-trimester spontaneous abortions (16). The findings were similar when the analysis was restricted to only first-time pregnancies. In patients with multiple pregnancies, the outcome of a subsequent pregnancy was not predicted by the outcome of the first. In general, in successful cases the last two trimesters were mostly uneventful, with healthy offspring being reported in all cases. Conclusions: Pregnant patients with ET have an increased risk of first-trimester abortion which is not predictable by preconception platelet count or aspirin therapy, in addition, our experience does not support the use of prophylactic platelet apheresis during delivery.

Original languageEnglish (US)
Pages (from-to)152-159
Number of pages8
JournalEuropean Journal of Haematology
Volume66
Issue number3
DOIs
StatePublished - 2001

Fingerprint

Essential Thrombocythemia
Spontaneous Abortion
First Pregnancy Trimester
Pregnancy
Aspirin
Platelet Count
Abruptio Placentae
Multiple Pregnancy
Blood Component Removal
Stillbirth
Ectopic Pregnancy
Premature Birth
Third Pregnancy Trimester
Live Birth
Pregnancy Outcome
Heparin
Therapeutics
Blood Platelets

Keywords

  • Chronic myeloproliferative diseases
  • Essential thrombocythemia
  • Hemorrhage
  • Pregnancy
  • Thrombosis

ASJC Scopus subject areas

  • Hematology

Cite this

A single institutional experience with 43 pregnancies in essential thrombocythemia. / Wright, Curtis A.; Tefferi, Ayalew.

In: European Journal of Haematology, Vol. 66, No. 3, 2001, p. 152-159.

Research output: Contribution to journalArticle

@article{3c9efb6779c94805afa0068d51814e91,
title = "A single institutional experience with 43 pregnancies in essential thrombocythemia",
abstract = "Objectives: We describe the periconception circumstances and outcome of 43 consecutive pregnancies in an unselected group of young women with essential thrombocythemia (ET). Patients and methods: We retrospectively studied 74 consecutive cases of young women with ET seen at our institution, among whom 43 pregnancies occurred in 20 patients. Results: Of the 43 pregnancies, 22 (51{\%}) were successful (21 term and 1 preterm live births) and 21 (49{\%}) ended in miscarriages (1 ectopic pregnancy, 2 elective abortions, 16 first-trimester spontaneous abortions, 1 stillbirth at 22 wk, and 1 abruptio placentae at 33 wk). Management of ET at the time of conception included either no specific therapy (16 cases) or the use of aspirin alone (24 cases), a cytoreductive agent (2 cases), or heparin (1 case). There were no significant differences with respect to platelet count or the effect of treatment with aspirin, either at the time of conception or during the first trimester, among cases of successful pregnancies (22), all miscarriages (21), or first-trimester spontaneous abortions (16). The findings were similar when the analysis was restricted to only first-time pregnancies. In patients with multiple pregnancies, the outcome of a subsequent pregnancy was not predicted by the outcome of the first. In general, in successful cases the last two trimesters were mostly uneventful, with healthy offspring being reported in all cases. Conclusions: Pregnant patients with ET have an increased risk of first-trimester abortion which is not predictable by preconception platelet count or aspirin therapy, in addition, our experience does not support the use of prophylactic platelet apheresis during delivery.",
keywords = "Chronic myeloproliferative diseases, Essential thrombocythemia, Hemorrhage, Pregnancy, Thrombosis",
author = "Wright, {Curtis A.} and Ayalew Tefferi",
year = "2001",
doi = "10.1034/j.1600-0609.2001.00367.x",
language = "English (US)",
volume = "66",
pages = "152--159",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A single institutional experience with 43 pregnancies in essential thrombocythemia

AU - Wright, Curtis A.

AU - Tefferi, Ayalew

PY - 2001

Y1 - 2001

N2 - Objectives: We describe the periconception circumstances and outcome of 43 consecutive pregnancies in an unselected group of young women with essential thrombocythemia (ET). Patients and methods: We retrospectively studied 74 consecutive cases of young women with ET seen at our institution, among whom 43 pregnancies occurred in 20 patients. Results: Of the 43 pregnancies, 22 (51%) were successful (21 term and 1 preterm live births) and 21 (49%) ended in miscarriages (1 ectopic pregnancy, 2 elective abortions, 16 first-trimester spontaneous abortions, 1 stillbirth at 22 wk, and 1 abruptio placentae at 33 wk). Management of ET at the time of conception included either no specific therapy (16 cases) or the use of aspirin alone (24 cases), a cytoreductive agent (2 cases), or heparin (1 case). There were no significant differences with respect to platelet count or the effect of treatment with aspirin, either at the time of conception or during the first trimester, among cases of successful pregnancies (22), all miscarriages (21), or first-trimester spontaneous abortions (16). The findings were similar when the analysis was restricted to only first-time pregnancies. In patients with multiple pregnancies, the outcome of a subsequent pregnancy was not predicted by the outcome of the first. In general, in successful cases the last two trimesters were mostly uneventful, with healthy offspring being reported in all cases. Conclusions: Pregnant patients with ET have an increased risk of first-trimester abortion which is not predictable by preconception platelet count or aspirin therapy, in addition, our experience does not support the use of prophylactic platelet apheresis during delivery.

AB - Objectives: We describe the periconception circumstances and outcome of 43 consecutive pregnancies in an unselected group of young women with essential thrombocythemia (ET). Patients and methods: We retrospectively studied 74 consecutive cases of young women with ET seen at our institution, among whom 43 pregnancies occurred in 20 patients. Results: Of the 43 pregnancies, 22 (51%) were successful (21 term and 1 preterm live births) and 21 (49%) ended in miscarriages (1 ectopic pregnancy, 2 elective abortions, 16 first-trimester spontaneous abortions, 1 stillbirth at 22 wk, and 1 abruptio placentae at 33 wk). Management of ET at the time of conception included either no specific therapy (16 cases) or the use of aspirin alone (24 cases), a cytoreductive agent (2 cases), or heparin (1 case). There were no significant differences with respect to platelet count or the effect of treatment with aspirin, either at the time of conception or during the first trimester, among cases of successful pregnancies (22), all miscarriages (21), or first-trimester spontaneous abortions (16). The findings were similar when the analysis was restricted to only first-time pregnancies. In patients with multiple pregnancies, the outcome of a subsequent pregnancy was not predicted by the outcome of the first. In general, in successful cases the last two trimesters were mostly uneventful, with healthy offspring being reported in all cases. Conclusions: Pregnant patients with ET have an increased risk of first-trimester abortion which is not predictable by preconception platelet count or aspirin therapy, in addition, our experience does not support the use of prophylactic platelet apheresis during delivery.

KW - Chronic myeloproliferative diseases

KW - Essential thrombocythemia

KW - Hemorrhage

KW - Pregnancy

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=0035062679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035062679&partnerID=8YFLogxK

U2 - 10.1034/j.1600-0609.2001.00367.x

DO - 10.1034/j.1600-0609.2001.00367.x

M3 - Article

C2 - 11350483

AN - SCOPUS:0035062679

VL - 66

SP - 152

EP - 159

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 3

ER -